Peptides derived from apolipoprotein A-I (apoA-I), the main component of high-density lipoprotein (HDL), constitute the main component of amyloid deposits that colocalize with atherosclerotic plaques. Here we investigate the molecular details of full-length, lipid-deprived apoA-I after assembly into insoluble aggregates under physiologically relevant conditions known to induce aggregation <i>in vitro</i>. Unmodified apoA-I is shown to remain soluble at pH 7 for at least 3 days, retaining its native α-helical-rich structure. Upon acidification to pH 4, apoA-I rapidly assembles into insoluble nonfibrillar aggregates lacking the characteristic cross-β features of amyloid. In the presence of heparin, the rate and thioflavin T responsiveness of ...
The brains of Alzheimer’s disease (AD) patients contain large numbers of amyloid plaques that are ri...
AbstractApolipoprotein A-I (apoA-I) is deposited as amyloid within various major organs in hereditar...
The aggregation promoter heparin is commonly used to study the aggregation kinetics and biophysical ...
Peptides derived from apolipoprotein A-I (apoA-I), the main component of high-density lipoprotein (H...
In vivo, apolipoprotein A-I (ApoA-I) is commonly found together with lipids in so-called lipoprotein...
In amyloidosis associated with apolipoprotein A-I (ApoA-I), heart amyloid deposits are mainly consti...
Assemblies of different molecules is a prevalent phenomenon in nature, and crucial in biological lif...
In amyloidosis associated to Apolipoprotein A-I, heart amyloid deposits are mainly constituted by th...
Amyloid deposits of wild-type apolipoprotein A-I (apoA-I), the main protein component of high-densit...
High-density lipoproteins and their major protein, apolipoprotein A-I (apoA-I), remove excess cellul...
Amyloids are insoluble aggregates rich in β-structure that result from the self-assembly of polypept...
The N-terminal portion of apolipoprotein A-I corresponding to the first 93 residues has been identif...
Amyloid deposits in vivo are complex mixtures composed of protein fibrils and nonfibrillar component...
Transformation of proteins and peptides to fibrillar aggregates rich in β sheets underlies many dise...
<div><p>Aggregation of amyloid beta (Aβ) into oligomers and fibrils is believed to play an important...
The brains of Alzheimer’s disease (AD) patients contain large numbers of amyloid plaques that are ri...
AbstractApolipoprotein A-I (apoA-I) is deposited as amyloid within various major organs in hereditar...
The aggregation promoter heparin is commonly used to study the aggregation kinetics and biophysical ...
Peptides derived from apolipoprotein A-I (apoA-I), the main component of high-density lipoprotein (H...
In vivo, apolipoprotein A-I (ApoA-I) is commonly found together with lipids in so-called lipoprotein...
In amyloidosis associated with apolipoprotein A-I (ApoA-I), heart amyloid deposits are mainly consti...
Assemblies of different molecules is a prevalent phenomenon in nature, and crucial in biological lif...
In amyloidosis associated to Apolipoprotein A-I, heart amyloid deposits are mainly constituted by th...
Amyloid deposits of wild-type apolipoprotein A-I (apoA-I), the main protein component of high-densit...
High-density lipoproteins and their major protein, apolipoprotein A-I (apoA-I), remove excess cellul...
Amyloids are insoluble aggregates rich in β-structure that result from the self-assembly of polypept...
The N-terminal portion of apolipoprotein A-I corresponding to the first 93 residues has been identif...
Amyloid deposits in vivo are complex mixtures composed of protein fibrils and nonfibrillar component...
Transformation of proteins and peptides to fibrillar aggregates rich in β sheets underlies many dise...
<div><p>Aggregation of amyloid beta (Aβ) into oligomers and fibrils is believed to play an important...
The brains of Alzheimer’s disease (AD) patients contain large numbers of amyloid plaques that are ri...
AbstractApolipoprotein A-I (apoA-I) is deposited as amyloid within various major organs in hereditar...
The aggregation promoter heparin is commonly used to study the aggregation kinetics and biophysical ...